Matt Zuga, CFO & Chief Business Officer at Acumen Pharmaceuticals, Inc. (ABOS), sold 4,242 shares at $3.71 ($16K) on 2024-01-18, disclosed to the SEC on 2024-01-19.
Scheduled sale ($16k) by CFO & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ABOS | SELL | 2026-01-07 | $59K | — | Filing → |
| ABOS | SELL | 2025-01-23 | $57K | — | Filing → |
| ABOS | SELL | 2025-01-07 | $24K | — | Filing → |